Evidence map›Paper›PMID 35486370›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Protein Flexibility and Dissociation Pathway Differentiation Can Explain Onset of Resistance Mutations in Kinases.

Mrinal Shekhar, Zachary Smith, Markus A Seeliger, Pratyush Tiwary

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. ModBindProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Altered residence time as a cause of drug resistance.Current opinion in structural biology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Enhanced Sampling with Machine Learning.Annual review of physical chemistry · 2024
    Review
  9. Article
  10. Article
  11. Data-driven classification of ligand unbinding pathways.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mrinal ShekharCenter for Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Zachary SmithBiophysics Program and Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742, USA.
Markus A SeeligerDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794-8651, USA.ORCID 0000-0003-0990-1756
Pratyush TiwaryDepartment of Chemistry and Biochemistry and Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742, USA.ORCID 0000-0002-2412-6922

Funding

Dynamics of Ligand Binding and Protein Kinase Regulation_RenewalR35GM119437 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI Markus A Seeliger · 2016 to 2026
$6.5M
Robotic assay platformS10OD028478 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI SEELIGER, MARKUS A · 2020 to 2020
$173k
NIGMS NIH HHS R35 GM119437NIH HHS S10 OD028478
6 · The paper itself

Abstract

Understanding how mutations render a drug ineffective is a problem of immense relevance. Often the mechanism through which mutations cause drug resistance can be explained purely through thermodynamics. However, the more perplexing situation is when two proteins have the same drug binding affinities but different residence times. In this work, we demonstrate how all-atom molecular dynamics simulations using recent developments grounded in statistical mechanics can provide a detailed mechanistic rationale for such variances. We discover dissociation mechanisms for the anti-cancer drug Imatinib (Gleevec) against wild-type and the N368S mutant of Abl kinase. We show how this point mutation triggers far-reaching changes in the protein's flexibility and leads to a different, much faster, drug dissociation pathway. We believe that this work marks an efficient and scalable approach to obtain mechanistic insight into resistance mutations in biomolecular receptors that are hard to explain using a structural perspective.

Indexed as

BenzamidesPiperazinesDrug Resistance, NeoplasmFusion Proteins, bcr-ablImatinib MesylateMutationProtein Kinase InhibitorsPyrimidinesBenzamidesFusion Proteins, bcr-ablImatinib MesylatePiperazinesProtein Kinase InhibitorsPyrimidinesKinaseKineticsMolecular DynamicsProtein FlexibilityResistance Mutations

Identifiers

PMID35486370
PMCPMC9256798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.